Table of Contents

Clinical Studies

• You have access

  Cancer Immunotherapy by Intratumoral Injection of α-gal Glycolipids

  GILES F. WHALEN, MARY SULLIVAN, BILAL PIPERDI, WAHID WASSEFF and URI GALILI

  Anticancer Research September 2012, 32 (9) 3861-3868;
• You have access

  The Expression of CYP2W1: A Prognostic Marker in Colon Cancer

  KRISTINA STENSTEDT, MARIA HALLSTROM, INGER JOHANSSON, MAGNUS INGELMAN-SUNDBERG, PETER RAGNHAMMAR and DAVID EDLER

  Anticancer Research September 2012, 32 (9) 3869-3874;
• You have access

  Effectiveness of a 12-month Exercise Program on Physical Performance and Quality of Life of Breast Cancer Survivors

  TIINA SAARTO, HEIDI MARIKA PENTTINEN, HARRI SIEVÄNEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN, LIISA HAKAMIES-BLOMQVIST, RIKU NIKANDER, RIIKKA HUOVINEN, RIITTA LUOTO, HANNU KAUTIAINEN, SALME JÄRVENPÄÄ, IRJA IDMAN, MERI UTRIAINEN, LEENA VEHMANEN, ANNA-STINA JÄÄSKELÄINEN, ANNELI ELME, JOHANNA RUOHOLA, TIINA PALVA, HARRI VERTIO, MATTI RAUTALAHTI, MIKAEL FOGELHOLM, CARL BLOMQVIST and MINNA-LIISA LUOMA

  Anticancer Research September 2012, 32 (9) 3875-3884;
• You have access

  Chemotherapy Dose-intensity and Survival for Childhood Medulloblastoma

  R.L. SMITH, X. SHI and E.J. ESTLIN

  Anticancer Research September 2012, 32 (9) 3885-3892;
• You have access

  Gene Expression Profiling of Adult t(4;11)(q21;q23)-associated Acute Lymphoblastic Leukemia Reveals a Different Signature from Pediatric Cases

  ETIENNE DE BRAEKELEER, NATHALIE DOUET-GUILBERT, MARIE-JOSEE LE BRIS, AUDREY BASINKO, FREDERIC MOREL and MARC DE BRAEKELEER

  Anticancer Research September 2012, 32 (9) 3893-3899;
• You have access

  Update on PEG-Interferon α-2b as Adjuvant Therapy in Melanoma

  ROSSELLA DI TROLIO, ESTER SIMEONE, GIUSEPPE DI LORENZO, ANTONIO MARIA GRIMALDI, ANNA ROMANO, FABRIZIO AYALA, CORRADO CARACÒ, NICOLA MOZZILLO and PAOLO A. ASCIERTO

  Anticancer Research September 2012, 32 (9) 3901-3909;
• You have access

  Complete Pathologic Response to Neoadjuvant Radiotherapy is Predictive of Oncological Outcome in Patients with Soft Tissue Sarcoma

  DHRUVIL SHAH, DARIUSZ BORYS, STEVE R. MARTINEZ, CHIN-SHANG LI, ROBERT M. TAMURIAN, RICHARD J. BOLD, ARTA MONJAZEB and ROBERT J. CANTER

  Anticancer Research September 2012, 32 (9) 3911-3915;
• You have access

  Association of Matrix Metalloproteinase-1 Polymorphisms with Risk of COPD and Lung Cancer and Survival in Lung Cancer

  LINDSEY ENEWOLD, LEAH E. MECHANIC, ELISE D. BOWMAN, ELIZABETH A. PLATZ and ANTHONY J. ALBERG

  Anticancer Research September 2012, 32 (9) 3917-3922;
• You have access

  SERPINA1 and ELA2 Polymorphisms Are Not Associated with COPD or Lung Cancer

  LINDSEY ENEWOLD, LEAH E. MECHANIC, ELISE D. BOWMAN, ELIZABETH A. PLATZ and ANTHONY J. ALBERG

  Anticancer Research September 2012, 32 (9) 3923-3928;
• You have access

  Detection and Quantification of Human Papillomavirus in Benign and Malignant Parotid Lesions

  GÉRALDINE DESCAMPS, ANAËLLE DURAY, ALEXANDRA RODRIGUEZ, GILBERT CHANTRAIN, CHRISTOPHE E. DEPUYDT, PHILIPPE DELVENNE and SVEN SAUSSEZ

  Anticancer Research September 2012, 32 (9) 3929-3932;
• You have access

  Compliance, Analgesic Use and Side-effect Protection within a German Cohort of the TEAM Trial

  MICHAELA BOSSART, MEIKE BECKER, PEYMAN HADJI, DIRK G. KIEBACK and ANNETTE HASENBURG

  Anticancer Research September 2012, 32 (9) 3933-3938;
• You have access

  A Randomized Controlled Non-inferiority Study Comparing the Antiemetic Effect between Intravenous Granisetron and Oral Azasetron Based on Estimated 5-HT₃ Receptor Occupancy

  JUNKI ENDO, HIROTOSHI IIHARA, MAYA YAMADA, KOUMEI YANASE, FUMIHIKO KAMIYA, FUMITAKA ITO, NORIHIKO FUNAGUCHI, YASUSHI OHNO, SHINYA MINATOGUCHI and YOSHINORI ITOH

  Anticancer Research September 2012, 32 (9) 3939-3947;
• You have access

  Combining Paclitaxel and Lapatinib as Second-line Treatment for Patients with Metastatic Transitional Cell Carcinoma: A Case Series

  STÉPHANE CULINE, ZINEB SELLAM, LINDA BOUAITA, ELIAS ASSAF, CATHERINE DELBALDO, MURIEL VERLINDE-CARVALHO and DAMIEN POUESSEL

  Anticancer Research September 2012, 32 (9) 3949-3952;
• You have access

  Prediction of Recurrence after Complete Resection in Patients with NSCLC

  HIDETAKA URAMOTO and FUMIHIRO TANAKA

  Anticancer Research September 2012, 32 (9) 3953-3960;
• You have access

  Solitary Liver Lesions of Indeterminate Malignancy – Outcome Following Surgical Resection

  DANIEL ANSARI, GUNNAR NORDQVIST, PETER HAMMARLUND, JOSEF DANKIEWICZ, AMMAR MASSOUD and ROLAND ANDERSSON

  Anticancer Research September 2012, 32 (9) 3961-3964;
• You have access

  Expression of p53 and Ki-67 as Prognostic Factors for Survival of Men with Colorectal Cancer

  FRANCO LUMACHI, ROCCO ORLANDO, FILIPPO MARINO, GIORDANO B. CHIARA and STEFANO M.M. BASSO

  Anticancer Research September 2012, 32 (9) 3965-3967;
• You have access

  Health-related Quality of Life During Sequential Chemotherapy with Carboplatin Followed by Weekly Paclitaxel in Advanced Ovarian Cancer: A Multicenter Phase II Study of the North Eastern German Society of Gynecological Oncology

  ROLF RICHTER, GUELTEN OSKAY-OEZCELIK, RADOSLAV CHEKEROV, ADAK PILGER, HANS-JOACHIM HINDENBURG, HARALD SOMMER, OUMAR CAMARA, ELKE KEIL, JENS EINENKEL and JALID SEHOULI

  Anticancer Research September 2012, 32 (9) 3969-3976;
• You have access

  Association of Syndecan-1 with Angiogenesis-related Markers, Extracellular Matrix Components, and Clinicopathological Features in Colorectal Carcinoma

  ANTIGONY MITSELOU, URANIA SKOUFI, KONSTANTINOS E. TSIMOGIANNIS, EVAGELOS BRIASOULIS, THEODOROS VOUGIOUKLAKIS, DIMITRIS ARVANITIS and ELLI IOACHIM

  Anticancer Research September 2012, 32 (9) 3977-3985;
• You have access

  High Nuclear Protein Kinase CβII Expression Is a Marker of Disease Recurrence in Oral Squamous Cell Carcinoma

  PEI-YI CHU, NICHOLAS CHUNG-HENG HSU, SHU-HUI LIN, MING-FENG HOU and KUN-TU YEH

  Anticancer Research September 2012, 32 (9) 3987-3991;
• You have access

  The Expression of β-Microseminoprotein but Not CRISP3 Is Reduced in Ovarian Cancer and Correlates to Survival

  RUDI HENRIKSEN, ÅKE LUNDWALL, LENE UDBY and PER FERNLUND

  Anticancer Research September 2012, 32 (9) 3993-3999;
• You have access

  A Review of Dose-dense Temozolomide Alone and in Combination with Bevacizumab in Patients with First Relapse of Glioblastoma

  FREDRIK JOHANSSON, SIMON EKMAN, ERIK BLOMQUIST, ROGER HENRIKSSON, STEFAN BERGSTRÖM and MICHAEL BERGQVIST

  Anticancer Research September 2012, 32 (9) 4001-4006;
• You have access

  The Role of Cetuximab in the Treatment of Metastatic Colorectal Cancer

  LUBOS HOLUBEC, VACLAV LISKA, VIT M. MATEJKA, ONDREJ FIALA, JANA DRESLEROVA, PETRA MRAZKOVA, VLADISLAV TRESKA and JINDRICH FINEK

  Anticancer Research September 2012, 32 (9) 4007-4011;
• You have access

  Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study

  KUMIKO KARASAWA, FUMIHIKO MATSUMOTO, SIN ITO, SINICHI OBA, TOMOHISA FURUYA, HISAKO HIROWATARI, HIROMI IZAWA, KANA ITO and KEISUKE SASAI

  Anticancer Research September 2012, 32 (9) 4013-4018;
• You have access

  A Phase I Study of Concurrent Chemoradiotherapy and Cetuximab for Locally Advanced Esophageal Cancer

  CECILIE HOLLÄNDER, LENE BAEKSGAARD, MORTEN SORENSEN, PER ALBERTSSON, LARS DAMSTRUP and ULRIK LASSEN

  Anticancer Research September 2012, 32 (9) 4019-4023;
• You have access

  Role of Conservative (Palliative) Care-only in the Management of Advanced Malignant Pleural Mesothelioma

  ANTONIN LEVY, AVI ASSOULINE, SOFIA RIVERA, CYRUS CHARGARI and PATRICIA TAI

  Anticancer Research September 2012, 32 (9) 4025-4027;
• You have access

  Salvage Chemotherapy Using Gemcitabine for Taxane/Platinum-resistant Recurrent Ovarian Cancer: A Single Institutional Experience

  KIYOSHI YOSHINO, KOSUKE HIRAMATSU, TAKAYUKI ENOMOTO, MASAMI FUJITA, YUTAKA UEDA, TOSHIHIRO KIMURA, EIJI KOBAYASHI, YUMIKO KIYOHARA, TATEKI TSUTSUI and TADASHI KIMURA

  Anticancer Research September 2012, 32 (9) 4029-4033;
• You have access

  Feasibility of Concurrent Chemoradiotherapy with S-1 Administered on Alternate Days for Elderly Patients with Head and Neck Cancer

  YASUNAO KOGASHIWA, HIROSHI NAGAFUJI and NAOYUKI KOHNO

  Anticancer Research September 2012, 32 (9) 4035-4040;
• You have access

  Stereotactic Body Radiation Therapy for Stage I Non-small Cell Lung Cancer Patients with Chronic Respiratory Insufficiency Requiring Domiciliary Oxygen Therapy

  TADAMASA YOSHITAKE, KATSUMASA NAKAMURA, YOSHIYUKI SHIOYAMA, TOMONARI SASAKI, SAIJI OHGA, TAKESHI NONOSHITA, KOTARO TERASHIMA, KAORI ASAI, KEIJI MATSUMOTO and HIROSHI HONDA

  Anticancer Research September 2012, 32 (9) 4041-4044;
• You have access

  Systemic Inflammatory Response Predicts Perioperative Central Venous Catheter-related Bloodstream Infection in Patients Undergoing Colorectal Cancer Surgery with Administration of Parenteral Nutrition

  MITSURU ISHIZUKA, HITOSHI NAGATA, KAZUTOSHI TAKAGI, YOSHIMI IWASAKI and KEIICHI KUBOTA

  Anticancer Research September 2012, 32 (9) 4045-4050;
• You have access

  A Case of Synchronous Metastasis of Breast Cancer to Stomach and Colon

  HIDEYA TAKEUCHI, SHOZI HIROSHIGE, YASUJI YOSHIKAWA, TETUSYA KUSUMOTO and YOICHI MUTO

  Anticancer Research September 2012, 32 (9) 4051-4055;
• You have access

  Carcinoma of the Axillary Tail of Spence: A Case Series

  FEDERICO AMPIL, GLORIA CALDITO, BENJAMIN HENDERSON, BENJAMIN LI, ROGER H. KIM, GARY BURTON and QUYEN CHU

  Anticancer Research September 2012, 32 (9) 4057-4059;
• You have access

  Histological Grade Predicts for Recurrence in Patients with Uterine Endometrioid Carcinoma without Myometrial Involvement

  MARK A. ZAKI, JARED R. ROBBINS, SAIF FATTEH, MEREDITH G. MAHAN, RABBIE K. HANNA and MOHAMED A. ELSHAIKH

  Anticancer Research September 2012, 32 (9) 4061-4065;
• You have access

  High Levels of HMGB1 in Plasma May Be due to Ex Vivo Cell Necrosis

  PIOTR NOWAK, JESSICA NYSTROM and MARIUS TROSEID

  Anticancer Research September 2012, 32 (9) 4067-4069;
• You have access

  A Preliminary Study of Single Intraperitoneal Administration of Paclitaxel Followed by Sequential Systemic Chemotherapy with S-1 plus Paclitaxel for Advanced Gastric Cancer with Peritoneal Metastasis

  MOTOHIRO IMANO, YING-FENG PENG, TATSUKI ITOH, MASAYASU NISHIKAWA, TAKAO SATOU, ATSUSHI YASUDA, KEISUKE INOUE, HIROAKI KATO, MASAYUKI SHINKAI, MASAHIRO TSUBAKI, TAKUSHI YASUDA, HARUHIKO IMAMOTO, SHOZO NISHIDA, HIROSHI FURUKAWA, YOSHIFUMI TAKEYAMA, KIYOKATA OKUNO and HITOSHI SHIOZAKI

  Anticancer Research September 2012, 32 (9) 4071-4075;
• You have access

  Carotid Intima-media Thickness and Laboratory Parameters of Atherosclerosis Risk in Patients with Breast Cancer

  BOHUSLAV MELICHAR, HANA KALÁBOVÁ, LEOŠ UNGERMANN, LENKA KRČMOVÁ, RADOMÍR HYŠPLER, MARKÉTA KAŠPAROVÁ, MIROSLAV PECKA, VLASTISLAV ŠRÁMEK, HANA PROCHÁZKOVÁ-ŠTUDENTOVÁ, ADAM SVOBODNÍK, LADISLAV PECEN and DAGMAR SOLICHOVÁ

  Anticancer Research September 2012, 32 (9) 4077-4084;
• You have access

  Treatment Decision-making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific Evidence

  HRVOJE LUKETINA, CHRISTINA FOTOPOULOU, RUZICA-ROSALIA LUKETINA, ADAK PILGER and JALID SEHOULI

  Anticancer Research September 2012, 32 (9) 4085-4090;
• You have access

  Down-regulated Expression of ATG5 in Colorectal Cancer

  DONG-HYUNG CHO, YOON KYUNG JO, SEUNG CHEOL KIM, IN JA PARK and JIN CHEON KIM

  Anticancer Research September 2012, 32 (9) 4091-4096;
• You have access

  Colon Neoplastic Cells Do Not Originate from Bone Marrow-derived Cells after Sex-mismatched Bone Marrow Transplantation

  GEN SAKAI, TOMOHARU YAJIMA, HIROMASA TAKAISHI, TAKEHIKO MORI, HAJIME HIGUCHI, SHOKO NAKAMURA, SHINSUKE FUNAKOSHI, MASAYUKI ADACHI, MOTOKO IZUMIYA, HIDEKO AKAGI, YASUO HAMAMOTO, TAKANORI KANAI, MAKIO MUKAI, SHINICHIRO OKAMOTO and TOSHIFUMI HIBI

  Anticancer Research September 2012, 32 (9) 4097-4103;
• You have access

  Rapid Relapse after Resection of a Sunitinib-resistant Gastrointestinal Stromal Tumor Harboring a Secondary Mutation in Exon 13 of the c-KIT Gene

  HIROTOSHI KIKUCHI, SHINICHIRO MIYAZAKI, TOMOHIKO SETOGUCHI, YOSHIHIRO HIRAMATSU, MANABU OHTA, KINJI KAMIYA, TAKANORI SAKAGUCHI and HIROYUKI KONNO

  Anticancer Research September 2012, 32 (9) 4105-4109;
• You have access

  Cyclooxygenase-2 (COX-2) Up-regulation Is a Prognostic Marker for Poor Clinical Outcome of Upper Tract Urothelial Cancer

  HUNG-LUNG KE, HUNG-PIN TU, HUI-HUI LIN, CHEE-YIN CHAI, LIN-LI CHANG, WEI-MING LI, CHING-CHIA LI, YI-CHEN LEE, HSIN-CHIH YEH, WEN-JENG WU and DA-TIAN BAU

  Anticancer Research September 2012, 32 (9) 4111-4116;
• You have access

  Lenalidomide-associated Hepatotoxicity – A Case Report and Literature Review

  BORKO NOJKOV, CARINA SIGNORI, AMULYA KONDA and ROBERT J. FONTANA

  Anticancer Research September 2012, 32 (9) 4117-4119;
• You have access

  Hepatic Arterial Thrombosis: A Critical Complication During Combination Therapy of Arterial Chemoinfusion and Sorafenib

  HIDEYUKI NISHIOFUKU, TOSHIHIRO TANAKA, HIROSHI ANAI, SATORU SUEYOSHI, SHINSAKU MAEDA, TETSUYA MASADA and KIMIHIKO KICHIKAWA

  Anticancer Research September 2012, 32 (9) 4121-4124;
• You have access

  Influcence of Localization of Primary Tumor on Effectiveness of 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) in Patients with Metastatic Pancreatic Adenocarcinoma: A Retrospective Study

  VERONIQUE LORGIS, BRUNO CHAUFFERT, JULIE GENTIL and FRANÇOIS GHIRINGHELLI

  Anticancer Research September 2012, 32 (9) 4125-4130;
• You have access

  Feasibility Study of Zoledronic Acid plus Cisplatin-Docetaxel as First-line Treatment for Advanced Non-small Cell Lung Cancer with Bone Metastases

  KIYOTAKA YOH, KAORU KUBOTA, HIRONOBU OHMATSU, KOICHI GOTO, SEIJI NIHO and YUICHIRO OHE

  Anticancer Research September 2012, 32 (9) 4131-4135;
• You have access

  HE4 and ROMA Index in Czech Postmenopausal Women

  ZDENEK NOVOTNY, JIRI PRESL, RADEK KUCERA, ONDREJ TOPOLCAN, JINDRA VRZALOVA, RADKA FUCHSOVA, LUCIE BETINCOVA and ZDENEK ROKYTA

  Anticancer Research September 2012, 32 (9) 4137-4140;
• You have access

  Large Loop Excision of the Transformation Zone and Cervical Intraepithelial Neoplasia: A 22-Year Experience

  SOFIA M. STASINOU, GEORGE VALASOULIS, MARIA KYRGIOU, VASILIKI MALAMOU-MITSI, EVRIPIDIS BILIRAKIS, LINA PAPPA, EMMANOUIL DELIGEOROGLOU, MARIA NASIOUTZIKI, CHRISTINA FOUNTA, ALEXANDROS DAPONTE, GEORGE KOLIOPOULOS, ARISTOTELIS LOUFOPOULOS, PETROS KARAKITSOS and EVANGELOS PARASKEVAIDIS

  Anticancer Research September 2012, 32 (9) 4141-4145;
• You have access

  Gemcitabine-induced Pulmonary Toxicity

  DOW-CHUNG CHI, FRANCES BROGAN, ITHAMAR TURENNE, SARAH ZELONIS, LAWRENCE SCHWARTZ and MUHAMMAD WASIF SAIF

  Anticancer Research September 2012, 32 (9) 4147-4149;
• You have access

  Modified Docetaxel-cisplatin in Combination with Capecitabine as First-line Treatment in Metastatic Gastric Cancer. A Phase II Study

  ARISTIDES POLYZOS, EVANGELLOS FELEKOURAS, THEODORE KARATZAS, JOHN GRINIATSOS, DIMITRIOS DIMITROULIS, KOSTAS POLYZOS, KOSTAS KONTZOGLOU, DIMITRIOS MANTAS, JOHN KARAVOKYROS, NIKOLAOS NIKITEAS, NIKOLAS TSAVARIS, KOSTAS SYRIGOS and IRENE VAFIADIS

  Anticancer Research September 2012, 32 (9) 4151-4156;
• You have access

  Long-term Results of a Phase II Study of S-1 plus Irinotecan in Metastatic Colorectal Cancer

  SATORU IWASA, YASUHIDE YAMADA, KEN KATO, AYUMU GOTO, YOSHITAKA HONMA, TETSUYA HAMAGUCHI and YASUHIRO SHIMADA

  Anticancer Research September 2012, 32 (9) 4157-4161;
• You have access

  Use of Pretreatment Metabolic Tumor Volumes on PET-CT to Predict the Survival of Patients with Squamous Cell Carcinoma of Esophagus Treated by Curative Surgery

  WENG-YOON SHUM, HUEISCH-JY DING, JI-AN LIANG, KUO-YANG YEN, SHANG-WEN CHEN and CHIA-HUNG KAO

  Anticancer Research September 2012, 32 (9) 4163-4168;
• You have access

  Errata

  Anticancer Research September 2012, 32 (9) 4169;
• You have access

  Errata

  Anticancer Research September 2012, 32 (9) 4169;
• You have access

  Errata

  Anticancer Research September 2012, 32 (9) 4169;
• You have access

  Errata

  Anticancer Research September 2012, 32 (9) 4169;
• You have access

  Errata

  Anticancer Research September 2012, 32 (9) 4169;